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Analysis of glutamic acid decarboxylase (GDC) (EC 4.1.1.15) from Escherichia coli ATCC 11246 revealed the presence 
of six pyridoxal phosphates (PLPs) as well as six covalently bound pyrroloquinoline quinones (PQQs) per hexameric 
enzyme molecule. This is the second example of a pyridoxo-quinoprotein, suggesting that other atypical pyridoxoproteins 
(PLP-containing enzymes) have similar cofactor composition. Since the organism did not produce free PQQ and its qui- 
noprotein glucose dehydrogenase was present in the apo form, free PQQ is not used in the assemblage of GDC. Most 
probably, biosynthesis of covalently bound cofactor occurs in situ via a route which is different from that of free PQQ. 
Thus, organisms previously believed to be unable to synthesize (free) PQQ could in fact be able to produce quinoproteins 
with covalently bound cofactor. Implications for the role of PQQ in eukaryotic cells are discussed. 
Pyrroloquinoline quinone; Cofactor; Quinoprotein; Glutamic acid decarboxylase; Glucose dehydrogenase; Pyridoxal phosphate; 
(E. coh) 
1. INTRODUCTION 
A large number of Gram-negative bacteria pro- 
duce PQQ in their mineral culture medium when 
grown on substrates like methanol, ethanol or 
quinic acid, substrates which are frequently con- 
verted via a quinoprotein dehydrogenase by these 
organisms [1]. Those quinoprotein dehydrogenases 
investigated with respect o their localization ap- 
pear to occur in the periplasm. Therefore, the 
presence of PQQ in the spent medium can be ex- 
plained by assuming that the protein is transported 
in unfolded form across the cytoplasmic mem- 
brane and that reconstitution to holoenzyme oc- 
curs in the periplasm with PQQ which can escape 
through the outer membrane to the medium. The 
fact that immediate reconstitution to holoenzyme 
is observed on addition of PQQ to cells of PQQ- 
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mutants is in accordance with this view. Perhaps 
this phenomenon has significance in the natural 
environment in view of the occurrence of bacteria 
with quinoprotein dehydrogenase apo-enzymes 
and of PQQ overproducers [2]. 
Thus far quinoprotein dehydrogenases have not 
been detected in eukaryotic ells. On the other 
hand, several enzymes with covalently bound PQQ 
have been observed in eukaryotes [3]. Since many 
occur in mammals, the question as to whether 
PQQ functions as a vitamin is relevant. However, 
nothing is known about mammalian PQQ biosyn- 
thesis or the manner of assemblage of these 
quinoproteins o that the question cannot be 
answered at the moment. 
Tyrosine and glutamic acid are the precursors of 
bacterial PQQ biosynthesis [4,5]. In a search for 
intermediates in the route of biosynthesis, using 4 
genetically different classes of PQQ- mutants, no 
cross-feeding was observed [6]. Therefore, it has 
been suggested that the whole process occurs on a 
matrix where ring closure, hydroxylation, and ox- 
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idation proceed without any free intermediates, the 
final step being the excision of PQQ [7]. Extending 
this view, synthesis of the covalently bound cofac- 
tot does not require free PQQ but occurs in situ, 
i.e. in the quinoprotein itself, thus explaining why 
free PQQ has not been detected so far in mam- 
mals. The latter observation could, however, also 
be explained in a different way, namely by assum- 
ing that the cofactor is produced but cannot be 
detected due to the complexity of mammal ian 
systems. For instance, it is known that free PQQ 
readily reacts with nucleophilic ompounds (e.g. 
amino acids) and the products formed are un- 
detectable in a bioassay using a quinoprotein 
dehydrogenase apo-enzyme [3,7]. Therefore, to 
verify the hypothesis it would be necessary to 
examine an organism where the absence of free 
PQQ can be reliably assessed and subsequently to
determine whether it produces quinoproteins 
where the cofactor is covalently bound.  
Those common Escherichia coli laboratory 
strains which have been investigated appear to con- 
tain quinoprotein glucose dehydrogenase in the 
apo-form [8], indicating the absence of free PQQ. 
It is also known that certain strains produce 
glutamic acid decarboxylase (GDC) (EC 4.1.1.15), 
an enzyme which requires pyridoxal phosphate 
(PLP) for activity [9]. Based on its spectral 
behaviour when adding substrate, substrate 
analogues [10] or the inhibitor hydroxylamine [11], 
GDC is an atypical pyridoxoprotein (PLP- 
dependent enzyme). Since we recently found that a 
representative of this group, namely pig kidney 
aromatic-L-amino acid decarboxylase (EC 
4.1.1.28), contains covalently bound PQQ [12], 
GDC was investigated in order to ascertain the 
ability of E. coli to produce this form of the 
cofactor. 
2. MATERIALS  AND METHODS 
2.1. Purification of GDC 
GDC from E. coli ATCC 11246 (Sigma, type V) was purified 
by FPLC on a Superose HR 12 gel-filtration column (Phar- 
macia) in 0.1 M potassium phosphate buffer (pH 7.0) contain- 
ing 0.1 M NaCI. Fractions having an absorbance ratio of 
A28onm/A34onm = 12 (a ratio which can be derived from the ab- 
sorption spectrum presented in [13]) were pooled. This prepara- 
tion was adequate for cofactor analysis, since its absorption 
spectrum was identical to that reported for a homogeneous 
preparation [13]. Enzyme concentrations were calculated from 
the absorbance at 280 nm, measured in 0.1 M potassium 
phosphate buffer (pH 7.0), using an Z~nm value of 17 (at pH 
7.0) and an Mr of 310000 [141. 
2.2. PLP analysis 
The PLP content of the enzyme preparation was determined 
as described by Wada and Snell [15] as well as via the alkaline 
method [11,16] measuring the absorbance at388 nm in 0.1 M 
NaOH and using a molar absorption coefficient of 
6600 M -1 .cm -x. 
2.3. PQQ analysis 
Analysis was performed using the previously described [12] 
hexanol extraction procedure, xcept that some modifications 
were incorporated leading to only a single product. To a solu- 
tion of 7.5 ml enzyme (0.116 mg/ml) in 30 mM potassium 
phosphate buffer (pH 6.3) containing 30 mM NaCI, 7.5 ml of 
6 M HC1 and 10 ml hexanol were added. The mixture was 
refluxed for 30 min, after which the condenser was removed so 
that the water could evaporate. The remaining hexanol phase 
was refluxed for a further hour, transferred to a film 
evaporator and the hexanol removed under reduced pressure. 
The residue was dissolved in 1 ml methanol. HPLC was per- 
formed on a C8 reversed-phase column (Merck LichroCart 125 
× 4 ram; 4/~m particle size), using methanol with 0.5°70 H3PO4 
as eluant at a flow rate of 1.5 ml/min. Detection occurred with 
a Hewlett-Packard HP1040 A photodiode array detector, 
monitoring the eluting peaks at 318 nm and recording spectra 
throughout the chromatogram. 
2.4. Determination o f free PQQ 
Lyophilized E. coli ATCC 11246 cells (Sigma) were extracted 
with 9007o methanol, acidified to pH 2.0 with a HCI solution. 
After neutralization, free PQQ was determined ina biological 
assay [17]. The amount of quinoprotein glucose dehydrogenase 
holo-enzyme activity was determined as in [18]. Apo-enzyme 
'activity' was determined by incubating cell-free xtract with 
0.1 mM PQQ. 
3. RESULTS 
3.1. PLP  and PQQ in GDC 
Based on the procedure of Wada and Snell [15] 
and the alkaline method [11,16], the GDC prepara- 
t ion contained 5.1 and 7.4 PLP molecules per en- 
zyme molecule, respectively. In view of the 
relatively mild extraction conditions in the first 
method, PLP is non-covalently bound.  
HPLC of the residue obtained with the hexanol 
extraction method gave a product with retention 
time and absorption spectrum identical to those of 
the product prepared from authentic PQQ under 
the same condit ions (fig.l). The slightly different 
condit ions, as compared with those in [12], led tc 
only a single product, tH-NMR revealed it to be 
4-hydroxy-4-hexoxy-PQQ, having a molar absorp- 
t ion coefficient of 39900 M -1 -cm -1 at 318 nm (to 
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Fig.1. Chromatograms (left) and absorption spectra (right) of products obtained with the hexanol extraction procedure: (a) product 
extracted from GDC; (b) product prepared from authentic PQQ (4-hydroxy-5-hexoxy-PQQ). HPLC and photodiode array detection 
were performed as described in the text. 
be published elsewhere). Using this value, it was 
calculated that the GDC preparation contained 5.3 
PQQ molecules per enzyme molecule [no free PQQ 
was detected after acid-methanol extraction (see 
section 3.2) so that it is covalently bound]. Since 
GDC is a hexameric enzyme [14], this could in- 
dicate that each subunit contains one PLP and one 
covalently bound PQQ. 
3.2. Production o f free PQQ 
Free PQQ was not detected in the extract from 
the cells. The cells contained glucose dehydro- 
genase apo-enzyme (10nmol Wurster's Blue 
reduced/min per mg protein) but not holo-enzyme 
activity. 
4. DISCUSSION 
GDC is the second amino acid decarboxylase 
where the presence of covalently bound PQQ has 
been established, suggesting that other atypical 
pyridoxoproteins (present in the group of decar- 
boxylase as well as transaminases [12]) might also 
be pyridoxo-quinoproteins. A tentative proposal 
for a mechanism has already been put forward for 
dopa decarboxylase [3]. In the reaction cycle, PQQ 
is active in the decarboxylation step and PLP  func- 
tions as an acceptor for the amine product after 
which hydrolysis occurs. Since data suitable for 
deriving such a mechanism for GDC are rather 
sparse, a clear role of PQQ cannot be indicated. 
Nevertheless, it is very likely that the current 
mechanism for GDC, which is at present based 
solely on PLP as cofactor, should be revised in the 
near future. 
The finding of PQQ in GDC, but not in glucose 
dehydrogenase or in the cell (in free form), can be 
explained in several ways: 
(i) E. coil produces free PQQ at a level adequate 
for assemblage of GDC but not for glucose 
dehydrogenase. 
(ii) The route of PQQ biosynthesis n E. coli is in- 
complete and the intermediate which is 
formed is suitable for GDC but not for 
glucose dehydrogenase formation. 
(iii) Biosynthesis of the covalently bound cofactor 
does not start with free PQQ but proceeds in 
situ, i.e. in the quinoprotein itself. 
Explanation (i) is unlikely, since very low levels 
of PQQ are detectable with the assay used [18]. Ex- 
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planation (ii) is also unlikely, since it is expectable 
that such a compound would have been detected in
the search for (free) intermediates [6]. Therefore, 
explanation (iii) seems the most attractive at the 
moment. It suggests that biosynthesis of free and 
covalently bound cofactor proceeds via different 
routes. This is in accordance with the observation 
that production of glucose dehydrogenase holo- 
enzyme in E. coli requires incorporation of all 4 
genes for (free) PQQ biosynthesis cloned from 
Acinetobacter calcoaceticus LMD 79.41 [19]. 
Further support for explanation (iii) is provided 
by recently obtained insights into the structure of 
methylamine dehydrogenase (EC 1.4.99.3). This 
bacterial quinoprotein contains covalently bound 
PQQ (observed as the PQQ-hydrazone) when the 
hydrazine method is applied to it [20]. However, 
the determination of the 3-dimensional structure 
suggests that the cofactor in the active site is pro- 
PQQ, having the quinone-indole structure of PQQ 
connected with a glutamic acid residue which is 
bound to the protein chain at 2 positions (Vellieux, 
F.M.D. et al., to be published elsewhere). Ob- 
viously, ring closure of the glutamic acid moiety 
occurs easily during application of the hydrazine 
method (closure of this ring also proceeds 
smoothly in one of the chemical synthesis routes of 
PQQ [21]). Therefore, all other quinoproteins with 
covalently bound PQQ (established with the 
hydrazine method, and perhaps also with the hex- 
anol extraction procedure) might in fact contain 
pro-PQQ, thus representing another argument in 
favour of the presumption that cofactor biosyn- 
thesis occurs in situ in these cases. 
In summary, the detection of a quinoprotein i
E. coli suggests that organisms previously believed 
to be unable to produce PQQ are in fact capable 
of producing covalently bound cofactor (although 
it remains to be established whether it is in the 
form of PQQ or pro-PQQ). Since most of the en- 
zymes with covalently bound PQQ play a crucial 
role in the cell [7], it seems that quinoproteins are 
omnipresent although the ability to produce free 
PQQ is restricted to certain Gram-negative 
bacteria. This view implies that cofactor biosyn- 
thesis occurs in situ, excluding a direct effect as 
vitamin of free PQQ in eukaryotic ells. 
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